TrademarkDir
AGT AMERICAN GENE TECHNOLOGIES
DEAD

Serial Number

87180010

Owner

American Gene Technologies International Inc.

Attorney

William F. Mulholland II

Filing Date

Sep 22, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

AGT AMERICAN GENE TECHNOLOGIES Trademark

Serial Number: 87180010

AGT AMERICAN GENE TECHNOLOGIES is a trademark filed by American Gene Technologies International Inc. on September 22, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

American Gene Technologies International Inc. (6 trademarks)

9713 Key West Ave, 5th Floor
Rockville, MD 20850

Entity Type: 03

American Gene Technologies InternationalInc. (2 trademarks)

9640 Medical Center Drive
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

September 22, 2016

Registration Date

Not Registered

Published for Opposition

March 6, 2018

Goods & Services

Pharmaceuticals, medicinal and biological preparations for modulation of patient gene expression for the treatment of diseases and conditions associated with cancer, immunological based disorders, auto-immunological based disorders, and infectious disease as may be caused by viruses, bacteria, and fungi, and inherited diseases, namely, metabolic, skeletal, muscular, dermal and neurodegenerative disorders, and for the treatment of injury, trauma, burns, or bone fractures, namely, repair of vasculature and re-innervation of tissues, and cosmetic or reconstructive tissue modification

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 7, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 7, 2021 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2020 EXRA
SOU EXTENSION 5 GRANTED
Nov 5, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 5, 2020 AITU
SOU EXTENSION 5 FILED
Oct 28, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 28, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 10, 2020 EXRA
SOU EXTENSION 4 GRANTED
Mar 6, 2020 EX4G
SOU EXTENSION 4 FILED
Mar 6, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 6, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2019 EXRA
SOU EXTENSION 3 GRANTED
Aug 26, 2019 EX3G
SOU EXTENSION 3 FILED
Aug 26, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 26, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2019 EXRA
SOU EXTENSION 2 GRANTED
Apr 25, 2019 EX2G
SOU EXTENSION 2 FILED
Apr 25, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 25, 2019 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2018 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2018 EXRA
SOU EXTENSION 1 GRANTED
Oct 29, 2018 EX1G
SOU EXTENSION 1 FILED
Oct 29, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 29, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 1, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 6, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 14, 2018 NONP
ASSIGNED TO LIE
Jan 28, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 18, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 18, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 18, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 18, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 18, 2018 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 18, 2017 GNFN
FINAL REFUSAL E-MAILED
Jul 18, 2017 GNFR
FINAL REFUSAL WRITTEN
Jul 18, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 29, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 29, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 29, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 28, 2016 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2016 NWOS
NEW APPLICATION ENTERED
Sep 26, 2016 NWAP

Related Trademarks

More from this Owner

ADDIMMUNE

ADDIMMUNE

ADDIMMUNE

ADDIMMUNE

WHERE CREATIVITY CURES

WHERE CREATIVITY CURES

WHERE CREATIVITY CURES

WHERE CREATIVITY CURES

WHERE CREATIVITY CURES

WHERE CREATIVITY CURES

AGT logo

AGT